Skip to content

Recurrent Campylobacter Bacteraemia in Immunocompromised Patients

Recurrent Campylobacter Bacteraemia in Immunocompromised Patients: a Retrospective Nationwide Study in France, 2000-2025

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06432777
Acronym
CABARET
Enrollment
30
Registered
2024-05-29
Start date
2024-06-01
Completion date
2026-05-01
Last updated
2024-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Campylobacter Infections

Keywords

primary immunodeficiency, Campylobacter, Relapsing bacteraemia

Brief summary

Some rare cases of recurrent Campylobacter bacteraemia (RCB) exist with relapses months to years after an effective treatment and a negativation of all bacterial samples. As of today, only around 20 cases have been described in the international literature for the last 30 years. The cases are likely highly underreported. No study describes those recurrent Campylobacter bacteraemias at the scale of a country. The aim of this multicentre, nationwide, retrospective study is to describe their precise epidemiology in France for the last 25 years, the immune profile of the patients, the specificities of the bacteria involved, the treatments received and the evolution of these infections. The perspective is to propose a standardization of the medical care of those patients mainly by describing the effective treatments and the explorations of the immune system which should be considered.

Interventions

OTHERCharacteristics of patients and Campylobacter bacteraemia episodes

Variables: characteristics of the patients (demographic characteristics; characteristics of immunodeficiency: diagnosis, immunoglobulin dosage, white cells count etc.; chronic inflammatory bowel disease \[IBD\]), the bacteria (species, antimicrobial susceptibility) and the infection (clinical presentation, evolution, treatment received)

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 100 Years
Healthy volunteers
No

Inclusion criteria

* 2 episodes or more of Campylobacter bacteraemia separated by at least 60 days * AND immunodeficiency condition * followed by a French hospital

Exclusion criteria

-Opposition of the patient

Design outcomes

Primary

MeasureTime frameDescription
Description of the characteristics of the patients presenting with recurrent Campylobacter bacteraemiaBaseline-demographic characteristics

Countries

France

Contacts

Primary ContactAnne CONRAD, Dr
Anne.conrad@chu-lyon.fr+33 (0)4 72 07 11 07
Backup ContactNicolas BENECH, Dr
Nicolas.benech@chu-lyon.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026